NUTRA PHARMA CORP. (NPHC) Operating margin 2016–2025
NUTRA PHARMA CORP. (NPHC) operating margin by fiscal year — reported operating income divided by reported revenue.
-567.7%FY2025 · since FY2016: -1213.8% → -567.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -567.7% | -211.0 pp |
| FY2024 | -356.6% | +74.9 pp |
| FY2023 | -431.5% | +876.7 pp |
| FY2022 | -1308.2% | +726.3 pp |
| FY2021 | -2034.5% | -252.3 pp |
| FY2020 | -1782.3% | -604.1 pp |
| FY2019 | -1178.1% | +260.5 pp |
| FY2018 | -1438.7% | -296.4 pp |
| FY2017 | -1142.3% | +71.5 pp |
| FY2016 | -1213.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice